InsidersTradesSigma
Explore the complete record of transactions filed by Agajanian Richy, Dirigeant. Officer active across 1 companies, notably Oncology Institute, Inc.. Aggregated, 1 disclosures have been logged. Total volume traded: €7.7m. The latest transaction was disclosed on 11 May 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Richy Agajanian is an executive at Oncology Institute, Inc. He contributes to the company's leadership, focusing on operations and strategy. His role is crucial for the development and implementation of the institute's initiatives aimed at improving patient care.